Back to VA VANGUARD CAPITAL MANAGEMENT LLC

ICCCICCC
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in IMMUCELL CORP

Yes. Vanguard Capital Management holds 268,130 shares of ICCC (Immucell), worth $2.7M, as of its Q2 2026 13F filing. It increased the position by 7,803 shares (+3.0%) from Q1 2026. Vanguard Capital Management has held ICCC in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$2.7M

Current Shares

268,130

Total Value Change

+$1M

Total Shares Change

+7,803

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
268,130
+3.0%
$2.7M0.0%$10.05
27
2026-Q1
First report
260,327
-
$1.6M0.0%$6.33
0

Other major holders of ICCC: WELLINGTON MANAGEMENT GROUP LLP, MORGAN STANLEY, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used